Insulin-like growth factor inhibits vascular contraction to 5-hydroxytryptamine - Involvement of tyrosine phosphatase

Author： Melis A.   Watts S.W.   Florian J.   Klarr S.   Webb R.C.  

Publisher： Elsevier

ISSN： 0306-3623

Source： General Pharmacology, Vol.34, Iss.2, 2000-02, pp. : 137-145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Involvement of insulin-like growth factor 1 receptor transactivation in endothelin-1-induced signaling in vascular smooth muscle cells

By Bouallegue Ali   Vardatsikos George   Srivastava Ashok K.  

Canadian Journal of Physiology and Pharmacology, Vol. 88, Iss. 5, 2010-05 ,pp. : 501-509

NRC Research Press

Access to resources Recommend Favorite

The Involvement of Growth Hormone (GH), Insulin-Like Growth Factors (IGFs) and Vascular Endothelial Growth Factor (VEGF) in Diabetic Kidney Disease

By  

Current Pharmaceutical Design, Vol. 10, Iss. 27, 2004-10 ,pp. : 3385-3394

Bentham Science Publishers

Access to resources Recommend Favorite

Knockdown of Insulin-Like Growth Factor I Receptor Inhibits the Growth and Enhances Chemo-Sensitivity of Liver Cancer Cells

By  

Current Cancer Drug Targets, Vol. 12, Iss. 1, 2012-01 ,pp. : 74-84

Bentham Science Publishers

Access to resources Recommend Favorite

Insulin-Like Growth Factor I: Implications in Aging

By Arvat E.   Broglio F.   Ghigo E.  

Drugs & Aging, Vol. 16, Iss. 1, 2000-01 ,pp. : 29-40

Adis International

Access to resources Recommend Favorite

Insulin-like growth factor-I and parathyroid

By Rosen C.J.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 9, 1997-09 ,pp. : 1193-1198

Informa Healthcare

Access to resources Recommend Favorite